CB-FXa

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCB-FXa

Drug Alias NameCB 1965aFXarecombinant Factor X/Xa variant program (Catalyst Biosciences)recombinant FX/Xa series (Catalyst)Recombinant Factor X/Xa variant program (Catalyst Biosciences)

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionCoagulation factor X stimulantsCoagulation factor X modulators

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGyre Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGyre Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A